| Primary |
| Asthma |
22.4% |
| Drug Use For Unknown Indication |
18.4% |
| Dyspnoea |
12.2% |
| Lower Respiratory Tract Infection |
10.2% |
| Hyperkalaemia |
6.1% |
| Intentional Drug Misuse |
6.1% |
| Stridor |
6.1% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Premature Labour |
4.1% |
| Cough |
2.0% |
| Pneumonia |
2.0% |
| Respiratory Disorder |
2.0% |
| Thermal Burn |
2.0% |
| Tocolysis |
2.0% |
|
| Lactic Acidosis |
12.1% |
| Thermal Burn |
12.1% |
| Wheezing |
12.1% |
| Drug Exposure During Pregnancy |
6.1% |
| Myocardial Ischaemia |
6.1% |
| Pulmonary Oedema |
6.1% |
| Supraventricular Tachycardia |
6.1% |
| Asthma |
3.0% |
| Death |
3.0% |
| Drug Ineffective |
3.0% |
| Gestational Diabetes |
3.0% |
| Inappropriate Schedule Of Drug Administration |
3.0% |
| Intentional Drug Misuse |
3.0% |
| Intentional Self-injury |
3.0% |
| Respiratory Acidosis |
3.0% |
| Tachycardia |
3.0% |
| Tachypnoea |
3.0% |
| Therapeutic Agent Toxicity |
3.0% |
| Therapy Non-responder |
3.0% |
| Twin Pregnancy |
3.0% |
|
| Secondary |
| Asthma |
25.1% |
| Drug Use For Unknown Indication |
19.8% |
| Pneumonia |
14.5% |
| Ill-defined Disorder |
12.3% |
| Product Used For Unknown Indication |
10.6% |
| Schizophrenia |
2.2% |
| Hypertension |
1.8% |
| Anxiety |
1.3% |
| Bronchitis Acute |
1.3% |
| Cardiac Failure |
1.3% |
| Essential Hypertension |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Sleep Disorder |
1.3% |
| Superinfection |
1.3% |
| Tocolysis |
1.3% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Infection Prophylaxis |
0.9% |
| Abdominal Pain |
0.4% |
| Epilepsy |
0.4% |
| Foetal Growth Retardation |
0.4% |
|
| Drug Interaction |
12.2% |
| Tachycardia Foetal |
9.8% |
| Wheezing |
9.8% |
| Maternal Drugs Affecting Foetus |
7.3% |
| Renal Impairment |
7.3% |
| Toxic Epidermal Necrolysis |
7.3% |
| Vasculitis |
7.3% |
| Mesothelioma |
4.9% |
| Obesity |
4.9% |
| Ventricular Dysfunction |
4.9% |
| Angioedema |
2.4% |
| Cardiomyopathy |
2.4% |
| Condition Aggravated |
2.4% |
| Convulsion |
2.4% |
| Dyspnoea |
2.4% |
| Epilepsy |
2.4% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
2.4% |
| Lower Respiratory Tract Infection |
2.4% |
| Maternal Condition Affecting Foetus |
2.4% |
| Pneumonia |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.6% |
| Depression |
10.5% |
| Ill-defined Disorder |
9.2% |
| Non-small Cell Lung Cancer |
8.4% |
| Drug Use For Unknown Indication |
7.9% |
| Hypertension |
6.9% |
| Atrial Fibrillation |
5.1% |
| Multiple Myeloma |
4.3% |
| Asthma |
3.6% |
| Lower Respiratory Tract Infection |
3.6% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Prophylaxis |
2.8% |
| Antiviral Prophylaxis |
2.6% |
| Back Pain |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Lung Neoplasm Malignant |
2.6% |
| Pneumonia |
2.6% |
| Acute Myeloid Leukaemia |
2.1% |
| Prostate Cancer |
2.1% |
| Acute Coronary Syndrome |
1.7% |
|
| Vomiting |
14.8% |
| Pneumonia |
6.8% |
| Rash |
6.2% |
| Dyspnoea |
5.6% |
| Lower Respiratory Tract Infection |
5.6% |
| Wheezing |
5.6% |
| Palpitations |
4.9% |
| Renal Failure Acute |
4.9% |
| Tremor |
4.9% |
| Bronchiolitis |
4.3% |
| Thrombocytopenia |
4.3% |
| Hypercalcaemia |
3.7% |
| Malaise |
3.7% |
| Mesothelioma |
3.7% |
| Myositis |
3.7% |
| Nausea |
3.7% |
| Pyrexia |
3.7% |
| Tachypnoea |
3.7% |
| Anaemia |
3.1% |
| International Normalised Ratio Increased |
3.1% |
|
